COVID-19: AACE Statement Provides Guidance for People with Cushing’s Syndrome, Adrenal Insufficiency
The American Association of Clinical Endocrinologists (AACE) released a statement providing guidance for individuals with Cushing’s Syndrome and adrenal insufficiency as the novel COVID-10 virus spreads globally.
AACE urges those with uncontrolled Cushing’s Syndrome to follow the advice given by the Centers for Disease Control and Prevention (CDC) to help lessen the risk of infection as people with Cushing’s Syndrome are at a higher risk of infection in general. This includes maintaining social distance and contacting both the COVID-19 hotline and endocrinologist or primary care doctor if experiencing fever, cough, shortness of breath or other symptoms.
In the statement, AACE says that patients with adrenal insufficiency may have an increased rate of respiratory infection-related deaths, possibly due to impaired immune function. In addition to maintaining social distancing and taking prescribed medications, patients with adrenal insufficiency should try to have a 90-day supply of appropriate oral and injectable steroids at home.
See the full statement here.